A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Huangqi Guizhi Wuwutang granule in patients with rheumatoid arthritis
Discussion:
The findings of this research will elucidate the efficacy and safety of HGWG and provide an alternative treatment for RA. In addition, our data will benefit the clinical decision-making on active RA and possibly be incorporated into future guidelines.
Trial registration:
ClinicalTrials.gov ID: NCT03593837.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Clinical Trial Source Type: research
More News: Arthritis | Autoimmune Disease | China Health | Chronic Pain | Clinical Trials | Disability | Internal Medicine | Pain | Research | Rheumatoid Arthritis | Rheumatology | Study